Ulcerative Colitis
10 competing products in clinical development for Ulcerative Colitis.
Pipeline by Phase
Phase 23
Phase 35
Approved2
All Products (10)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Filgotinib Maleate | Eisai | Approved | Recruiting | 50 |
| Mirikizumab SC + Mirikizumab IV + Placebo SC | Eli Lilly | Phase 3 | Completed | 40 |
| CT-P13 SC (Infliximab) | Celltrion | Phase 3 | Completed | 40 |
| Tacrolimus | Astellas Pharma | Phase 3 | Completed | 40 |
| tacrolimus + Placebo | Astellas Pharma | Phase 3 | Completed | 40 |
| adalimumab + placebo | Eisai | Phase 3 | Completed | 40 |
| Mirikizumab | Eli Lilly | Phase 2 | Completed | 35 |
| Azathioprine + Placebo | Celltrion | Approved | Terminated | 35 |
| KHK4083 + Placebo | Kyowa Kirin | Phase 2 | Completed | 35 |
| Arm1 + Arm 2 | Zydus Lifesciences | Phase 2 | Completed | 35 |